Tsinghua AIR-incubated AI4S startup 'Aifei Zhiyao' secures hundred-million-yuan angel round | 36Kr First
Bubble signal: +1 · Overheating evidenceRelevance 55FundingChina
Source: 36Kr · Published 2026-09-03
Summary
Aifei Zhiyao, an AI-native drug discovery company incubated by Tsinghua University's AIR, has completed a hundred-million-yuan angel round led by Xianghe Capital. Funds will support R&D of drug foundation models and AI agent engines, and advance its own pipeline. The company uses a co-development model and has partnered with several pharma firms.
Bubble analysis
This is just an early-stage funding round for a single startup; the amount is notable but it's an isolated case and doesn't directly indicate the overall AI bubble. However, continued large investments in AI drug discovery show capital still flowing into AI applications, potentially inflating valuations.
#china#funding#startup#ai-drug-discovery
Read original ↗Related signals
linked by shared tags
- Photon held a funeral for mobile apps. Now it has $4.5M to help replace them with agents.#funding#startup
- Behind the 4 Trillion Compute Network: What Does the Tech Foundation of 'New Quality Productive Forces' Look Like?#china
- Qineng Technology's Datong Super Energy Complex Tianzhen Computing Park Phase I Tops Out#china
- Nvidia-Backed Firmus Plans Australian IPO at $30 Billion Target Valuation#funding
- An education company selling compute? Doushen Education lands an RMB 800 million cloud computing services order#china